• 대한환경공학회지
• /
• 제32권2호
• /
• pp.219-226
• /
• 2010

본 연구에서는 다양한 산화공정에서 chloramphenicol, salicylic acid 및 ketoprofen에 대한 제거특성을 평가하였다. 염소 투입농도에 따른 의약물질 3종의 제거특성을 살펴본 결과 chloramphenicol과 ketoprofen은 0.5~5.0 mg/L의 염소 투입농도에서 접촉시간 60분 동안 전혀 제거되지 않았으나 salicylic acid는 1.0 mg/L 이상의 염소 투입농도에서 제거경향이 뚜렷이 나타났며, 접촉시간 및 염소 투입농도가 증가할수록 제거율은 증가하였다. 오존 투입농도에 따른 의약물질 3종의 제거특성을 살펴본 결과 chloramphenicol과 ketoprofen은 0.2~2.0 mg/L의 오존 투입농도에서는 제거되지 않았으며, salicylic acid는 1.0~5.0 mg/L의 오존 투입농도에서 약 30~70%의 제거율을 보였다. 오존/과산화수소 투입농도별로 접촉시간에 따른 의약물질 3종의 제거특성을 살펴본 결과 오존단독 공정보다는 오존/과산화수소 공정에서의 제거율이 높았다. 염소, 오존 및 오존/과산화수소 투입농도별 의약물질 3종에 대한 산화분해 속도상수와 반감기를 살펴본 결과 염소, 오존 단독 투입에 비해 오존/과산화수소 공정에서의 산화분해 속도상수가 큰 것으로 나타났으며, 과산화수소/오존의 비가 1 이상에서는 산화분해 속도상수의 증가율이 둔화되었다. Salicylic acid의 경우는 염소와 오존처리에 의해서도 비교적 큰 산화분해 속도상수를 나타내어 산화공정에서 쉽게 제거가 가능하였다.

• Archives of Pharmacal Research
• /
• 제10권1호
• /
• pp.25-28
• /
• 1987

(+)-Ketoprofen was obtained form resolution with (S) (+)-2-amino-1-butanol and its absolute configuration was determined to be (S) by chemical correlation with (S) (+)-ethyl hydratropate using Beckmann rearrangement as a key step.

• 대한약학회:학술대회논문집
• /
• 대한약학회 2002년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.2
• /
• pp.410.2-411
• /
• 2002

Ketoprofen (KP), a potent analgesic and non-steroidal anti-inflammatory drug, has some disadvantages such as gastro-intestinal irritation. short half-life (1.5-4 hour) in plasma and low solubility in aqueous solution. In order to minimize these disadvantages. we have recently prepared a KP prodrug, KP-polyethylene glycol conjugate (KPEG750, PEG Mw=750), and investigated its pharmacokinetic behavior. anti-inflammatory and analgesic effect. (omitted)

• 한국임상수의학회지
• /
• 제31권3호
• /
• pp.220-222
• /
• 2014

14년령의 Shih-Tzu 개가 이물섭취 및 구토를 주 증으로 본원에 내원하였다. 구토물은 인의에서 사용되는 부착형 제제인 ketoprofen plaster 였다. 대증치료로 위장관 보호제 투여와 수액요법을 실시하였다. 하지만 임상증상은 점점 악화되어 빈혈 및 흑색변, 백혈구 증가증, 고지혈증이 관찰되었다. 환자는 위장관 출혈이 있는 것으로 평가되었고, 수혈 및 위장관 보호제로 바륨제제를 도포하였다. 바륨제제를 위장관 보호제로 사용한 후 임상증상의 개선이 확인 되었다.

• The Korean Journal of Pain
• /
• 제12권2호
• /
• pp.211-216
• /
• 1999

Background: Transdermal fentanyl patch (TDFP) is a simple, noninvasive analgesic with continuous effect. The aim of this study was to evaluate the postoperative analgesic effect of TDFP. Methods: Sixty healthy patients undergoing cesarean section were divided into 3 groups. Postoperative pain was controlled with different methods; Group I: application of TDFP-$25{\mu}g/hr$, Group II: intramuscular injection of ketoprofen; Group III: continuous epidural block. Pain scores (numerical rating scale, NRS), number of patients who needed additive ketoprofen injections and side effects were recorded at 8, 20, 32, 44 hours postoperatively. Results: There was no significanant difference in pain score between Group I and Group II. The numbers of patients who need additive ketoprofen injections were lower in group I than group II. Pruritis (25%), nausea/vomiting (10%), leg numbness (40%) was experienced in group III, but not in Group I & II. Conclusions: TDFP-$25{\mu}g/hr$ for postoperative pain control is simpler and more convinient than intramuscular injection of analgesics.

• Journal of Pharmaceutical Investigation
• /
• 제26권4호
• /
• pp.245-256
• /
• 1996

Solid lipid nanoparticles (SLN) have been developed as a new drug delivery system. Although many particulate drug carriers, such as microsphere, liposome, niosome, emulsion, etc. have been introduced, they have some disadvantage; low efficiency of incorporation and stability, lack of reproducibility, and so on. Meanwhile, SLN as a new drug delivery system is known to entrap rugs with a high efficiency and a good reproducibility. Moreover, small size SLN can circulate in blood for a prolonged time. Although many preparation methods were introduced, microfluidization method is recommended to be the most useful. This study was attempted to prepare and evaluate ketoprofen-incorporated SLNs (keto-SLN), which were prepared by two methods, ultrasonication and microfluidization. Keto-SLN was evaluated by measurement of particle size and zeta potential, efficacy of entrapment, sedimentation volume, in virto release pattern. The mean particle size was about $0.1\;{\mu}m$, and the size was dependent on the type and the amount of emulsifier. Zeta potential was negative, $-9{\sim}-13mV$ and entrapment efficacy was very high and stability was good for at least 60 days in the respect of particle size and sedimentation volume ratio. Analgesic effect was also determined as well as pharmacokinetic parameters. The former was comparable to that of that of ketoprofen loaded suspension (keto-sus) and the latter revealed that consistent with the delayed release of keto-SLN. $T_{max}$ was longer than keto-sus. Therefore, keto-SLN was favourable dosage forms in the field of drug delivery system such as anti-cancer, analgesics and anti-inflammatory agents.

• 한국생물공학회:학술대회논문집
• /
• 한국생물공학회 2001년도 추계학술발표대회
• /
• pp.652-655
• /
• 2001

The comparative study of enzymes that catalyze a similar reactions but have different substrate spectrum and/or stereospecificity is a powerful approach to understanding the reaction mechanism between the relative enzymes, and it was also an useful tool to cloning the related enzyme, without the typical cloning from DNA library of genomic pools. For this purpose, we conducted an approach that the comparison at the molecular and protein level of esterases, from various sources including a previously identified (S)-stereospecific esterase of Pseudomonas sp. ES1. As expected, we found an esterase family genes that shared a high similarity at the protein and genetic level in the identical genus Pseudomonad. The striking structural and biochemical identity strongly suggested the family genes to be an identical one. We, hence, aligned the family genes and designated a degenerated primer for PCR-cloning using six Pseudomonas strains as templates. As a result, a recombinant esterase from Pseudomonas fluorescens KCTC 1767 was cloned and high-level expressed with high selectivity to (R,S)-ketoprofen ethyl ester. The enzyme exhibited a high ester-hydrolyzing activity to (S)-ketoprofen but did not hydrolyzed the opposite stereoisomer. Further characteristics were discussed in our presentation.

• 한국생물공학회:학술대회논문집
• /
• 한국생물공학회 2002년도 생물공학의 동향 (X)
• /
• pp.445-448
• /
• 2002

The Pseudomonas fluorescens KCTC 1767, a selected and identified as potential candidate for stereo-specific resolution of rac-ketoprofen ethyl ester, was systematically investigated in order to induce the high level expression and detailed characterization of the expressing enzyme esterase. We cloned the esterase gene from chromosomal DNA of Pseudomonas fluorescens KCTC 1767 by PCR with two synthetic primers that desinged for simple purification. The recombinant esterase from Pseudomonas fluorescens KCTC 1767 exibited a high conversion rate and enantioselectivity to the (S)-ketoprofen ethyl ester as expected. The enzyme was easily purified to homogeniety by using a metal chelating affinity chromatography as a protein with poly histidine taq, and thus obtained 0.6 mg of protein from a 100 mL culture broth in a single step. The purified enzyme was steadily stable at the pH range from 7.0 to 10. The activity was also retained to be about 70% after the preincubation at $40^{\circ}C$ but over $50^{\circ}C$ lost the activity completely. The molecular mass of the esterase was estimated to be about 43 kDa on SDS-PAGE, and an identical result was also shown in gel filteration chromatography. The specific activity was calculated 27 mM/mg-protein/min by using the rac-ketoprofen ethly ester as a substrate.

• 약학회지
• /
• 제45권5호
• /
• pp.506-512
• /
• 2001

Ketoprofen (KP) was formulated as a transdermal patch using the percutaneous penetration enhancers sorbitan monmmleate(SMO), polyvinylpyrrolidone(PVP). The control patch without penetration enhancers showed a KP flux of 8.9$\pm$0.75$\mu\textrm{g}$/$\textrm{cm}^2$/h The flux was increased in proportion to the concentration of SMO added. Furthermore, lag times were decreased upon addition of SMO. Conversely; the skin flux of KP was decreased in proportion to the concentration of PVP added. Pharmacokinetic parameters including $C_{max}$, $T_{max}$, and AUC were increased when SMO was added. However, $C_{mas}$ significantly decreased by the addition of PVP. $T_{max}$ was not significantly different in 2%, 4%, and 8% PVP patches. Patches containing 4% PVP showed the highest AUC value (19.158$\mu\textrm{g}$.h/ml). We found that the effectiveness of the two percutaneous penetration enhancers for topical KP patches was similar, with the addition of appropriate amounts of HPC modifying both skin flux and lag time of KP in the patches. In conclusion, it is possible to manufacture KP patches exhibiting high AUC, high skin flux, and short lag time using percutaneous penetration enhancers of SMO and PVP.

• Journal of Pharmaceutical Investigation
• /
• 제22권1호spc1호
• /
• pp.17-29
• /
• 1992